Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline in Pediatric Patients With Complicated Intra-abdominal Infections (cIAI)
NCT06794541Phase 2Recruiting
- Sponsor
- Tetraphase Therapeutics
- Start
- May 2025
- Primary completion
- Feb 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eravacycline in Intra-abdominal infection (IAI), sponsored by Tetraphase Therapeutics. Started May 2025; status: recruiting.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT06794541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06794541.